Mathes Company’s Allergan Inc AGN Stock Holding History

Mathes Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,625	Closed	-$305K	–	85
2013 Q2	$305K	Buy	+3,625	New	+$376K	0.33%	67

Other funds holding AGN

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mathes Company's AGN Position: Q3 2013 in Review

Mathes Company sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 3,625 shares — an estimated $305K sold.

Mathes Company first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $305K in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

Mathes Company reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
Mathes Company sold 3,625 Allergan Inc shares in Q3 2013, an estimated $305K.
Mathes Company first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
Mathes Company's Allergan Inc position peaked at $305K in Q2 2013.
642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Mathes Company's 13F filing for Q3 2013, filed 28 Oct 2013.